What's It Like Being A First-Time Biopharma CEO?
By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL
Since the CEO position comes with such high expectations and stress, we thought it would be interesting to speak with three first-time CEOs to hear their tales of the good, the bad, and the ugly.
In this edited transcript of our June 2021 executive virtual roundtable (EVR), perspectives are provided by Roger Crystal, CEO, Opiant Pharmaceuticals; Frank Lee, CEO, Forma Therapeutics; and Ivana Magovcˇevic´-Liebisch, Ph.D., JD, CEO, Vigil Neuroscience.
If you like what you read but have not yet watched/listened to the video/audio of this EVR, be sure to check it out, because not all of it could be squeezed into this print version.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.